| DB ID | MyCo_1446 |
| Title | CT evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis |
| Year | 2019 |
| PMID | 30765182 |
| Fungal Diseases involved | Allergic bronchopulmonary aspergillosis |
| Associated Medical Condition | Cystic fibrosis |
| Genus | Aspergillus |
| Species | spp. |
| Organism | Aspergillus spp. |
| Ethical Statement | The study was approved by the Local Ethic Committee (registration number: DC 2016/78). |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Biopsy |
| Sample source | Extracted Mucosal Tissue |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | HAM |
| Biomarker Full Name | Hyperattenuating mucus |
| Biomarker Type | Diagnostic |
| Biomolecule | None |
| Geographical Location | France |
| Cohort | The study was retrospective and included 137 patients with CF, aged greater than 6-year-old. |
| Cohort No. | 137 |
| Age Group | Dec-23 |
| P Value | p<0.001 |
| Sensitivity | 0.69 |
| Specificity | 1 |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | CT Scan |
| Analysis Method | CT Scan |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | CT Scan |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |